Concepedia

Hua Jiang

HJ

Statistics

Publications

65

Citations

5K

H-Index

39

Active since

1992

Affiliations

State Key Laboratory of Oncogene and Related Genes(Current)

Shanghai Cancer Institute

Renji Hospital

Shanghai Jiao Tong University

Second Military Medical University

Hua Jiang is an author at State Key Laboratory of Oncogene and Related Genes specializing in oncology, medicine, and cancer immunotherapy.

ORCID

Publications per year

1992–2023

65

Publications

65

Exploratory trial of a biepitopic CAR T-targeting B cell maturation antigen in relapsed/refractory multiple myeloma

Jie Xu, Lijuan Chen, Shuangshuang Yang et al. · Proceedings of the National Academy of Sciences · 2019 · 407 citations · Full text

, , +17

Chimeric Antigen Receptor-Glypican-3 T-Cell Therapy for Advanced Hepatocellular Carcinoma: Results of Phase I Trials

Donghua Shi, Ahmed O. Kaseb, Xingxing Qi et al. · Clinical Cancer Research · 2020 · 366 citations

, , +17

Development of T Cells Redirected to Glypican-3 for the Treatment of Hepatocellular Carcinoma

Huiping Gao, Kesang Li, Hong Tu et al. · Clinical Cancer Research · 2014 · 308 citations

, , +12

Claudin18.2-Specific Chimeric Antigen Receptor Engineered T Cells for the Treatment of Gastric Cancer

Hua Jiang, Zhimin Shi, Peng Wang et al. · JNCI Journal of the National Cancer Institute · 2018 · 248 citations

, , +17

Disruption of PD-1 Enhanced the Anti-tumor Activity of Chimeric Antigen Receptor T Cells Against Hepatocellular Carcinoma

Xingliang Guo, Hua Jiang, Bizhi Shi et al. · Frontiers in Pharmacology · 2018 · 205 citations · Full text

, , +17

1–5 of 65